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The paper by Andrew Trehearne1 about the UK Biobank in this
issue of the International Journal of Surgery is to be welcomed. It is
important that everybody learns more about this project: most
people are aware of it thanks to the fact that it has been widely
promoted to both the general public and health professionals.
When the UK Biobank opened its doors in Liverpool in January
2009, about 2 years after its launch in April 2007 in Manchester,
(already at about the halfway mark in recruiting its target of half
a million participants) the excitement of the moment was caught
by it being described as a project that would, as it matured, become
‘‘an unparalleled treasure chest of vital information on a range of
diseases including cancer, heart disease, diabetes, stroke, dementia,
depression, arthritis, osteoporosis, skin and lung disorders and
many other life-threatening and debilitating conditions.’’2 It leads
one to wonder what the factors were that contributed to achieving
this very rapid recruitment rate. Perhaps we can learn from this
model?911.
ciates Ltd. Published by Elsevier Lt2. Good communication: the key to effective collaboration
When Biobank is fully mature it will provide a major resource for
health scientists seeking to improve our knowledge, understanding
and handling of many diseases. But, as Dr. Tim Sprousen, the UK
Biobank Chief Scientist identiﬁed, it has already yielded one of its
most important ﬁndings that should be noted byanyone undertaking
collaborative research – researchwith people rather than on people.
This is the ﬁnding he mentioned: that when people feel properly
informed they will respond in the positive. He also said: ‘‘People
support research, andwilldoso ingreatnumbers if theyhave theright
information tohand.’’ Therein lies thekey– taking care toprovide ‘the
right information’ in a timely fashion. Scrutiny of Biobank’s methods
described in Trehearne’s editorial, and elaborated elsewhere, shows
that thisdidnothappenbychance. Bywayofa randomexampleof the
care that was taken, in June 2005 the UK Biobank Ethics and Gover-
nance Council3 were giving careful consideration to the suitability of
thepatient information leaﬂet at the timeof thepilot progress report:
‘‘The Patient Information Leaﬂet (PIL) will be evaluated according
to these three aspects of the participant‘s experience:
C What did the participant think of the invitation letter?
C What was the participants‘ (sic) expectation of the assessment
centre visit?
C Was there any aspect of the assessment visit that the participant
had not anticipated and/or had been surprised by?’’d. All rights reserved.
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with them, demonstrated that by careful communication and thor-
ough planning by a multi-talented team, using well thought-out and
imaginative strategies, ensured that when the letter of invitation
dropped through the letterbox of a prospective participant, the
recipientwouldhave agood ideawhat theprojectwasabout, and that
their GP and practice manager would too. It is reported that the UK
Biobank Information Centre at Cardiff University has beenwell used,
mostly by peoplewanting to knowmore about the project. Any piece
of research, no matter whether large or small, whether it is
a randomized controlled trial, a survey or a public consultation
seeking respondents, will produce better quality information, more
rapidaccrual andmoreuseful data if careful planningandpreparation
is undertaken to achieve good understanding and co-operation. This
exploration should include thorough consideration of the manner of
approachtopotential participants. Thismay insome instances require
pre-research qualitative studies which may, amongst other things,
help to determine participants’ information needs (or even health
professionals’ information needs4) as well as their attitude to the
acceptability of the study being proposed5 – and themanner inwhich
it is being offered. Imposed research is doomed to failure: ‘‘the
people’s health is the concern of the people themselves’’.6 Feasibility
or pilot studies (such as undertaken for Biobank in Altrincham,
Cheshire, in 2007, the year before launch) can help to reveal any
shortcomings or ﬂaws that need remedying before a project becomes
fully operational. Today, there is a range of researchmethods to draw
on to suit the particular requirements and objectives of a proposal.7
3. Trust, conﬁdence and altruism
As described by Trehearne, from the moment participation starts
with the receipt of the letter of invitation to attend for a 90-min
assessmentvisit, potentialparticipantsare treatedwithconsideration,
courtesy and respect. Although participants are providedwith a list of
their measurements at the end of the visit, and some attempt at
putting them into context, they know theywill receive no feedback at
any stage – it is not a health-check. This means that members of the
public have given their time, their data, their samples, knowing that
theyare contributing to anenterprise that aims to improve thehuman
lot rather than be of beneﬁt individually. But that is not all that they
have given: they have placed their trust in the people responsible for
UK Biobank’s work and exhibited conﬁdence in the processes and
systems put in place to secure their safety and protection. They are
aware that signing up to this communal effortwill not bring beneﬁt to
thempersonally, but evidently feel it isworth doing because it will be
of beneﬁt tonumerousothers in the future.Not just theirownkithand
kin, but unknown strangers anywhere. They might be surprised to
know that they have contributed to ‘prospective epidemiology’!
That altruism is alive andwell in a technological,materialistic age
is a cause for rejoicing. It gives witness to a high level of trust:
trusting members of the public giving their personal data, trusting
those collecting the data to handle it securely and safely so that it
might be used for the common good in decades to come. This trust
presupposes conﬁdence in theprocesses andsystems thathavebeen
set up to obtain, handle and store data and samples, and to ensure
that these datawill be properly drawn on and used for the purposes
for which they were obtained. But those setting up this giant data-
bank had in the ﬁrst place to trust that ordinary members of the
public would come forward to reciprocate that trust. Their trust was
earned, not blindly given.
4. Vision
Those who had the vision to plan and set up UK Biobank will
have drawn hope and inspiration from two fruitful long-termprospective epidemiological studies that Trehearne mentions: Sir
Richard Doll’s project to ﬁnd out what caused lung cancer8 and
the Framingham Heart Study.9 It is instructive for us to look back
at this work that Sir Richard began with Sir Austin Bradford Hill
in 194810 in order to remind ourselves of those early days of
epidemiology; what took place, the slow pace of change, the
general reluctance to accept ﬁndings or take action about
smoking. It is pleasing to think that Sir Richard lived long enough
to witness the outcome of his vision to accomplish this meticu-
lous, ground-breaking work. It also provides a salutary lesson:
that objectivity and patience are required by those who aspire to
producing reliable data resources.
The Framingham Heart study, also begun in 1948, was ‘‘an
ambitious project in health research to identify the common factors
that contribute to cardiovascular disease’’. Development of the
disease was followed over a long period of time in a large group of
participants. Of particular interest is the Study Bibliography which
shows a bar chart of ‘Articles Published per Decade Based on Fra-
mingham Data’ over the last 6 decades: a total of 1973 articles,
increasing in number through all six decades, from15 in 1950–1959
rising steadily through to 785 in 2000–2008.5. Conclusion
It is difﬁcult to avoid superlativeswhen considering the potential
of the Biobank ‘treasure chest’ to make an impact on health care
when it is fully ﬁlled, particularly remembering the means we have
at our disposal today for safe storage, retrieval and use of data. This
time of data-gathering is ideal for promoting optimism. Just as Sir
RichardDoll andSirAustinBradfordHill’sworkand theFramingham
Heart Study have provided inspirational models for worthwhile
long-term endeavours, this project should serve as a model to
demonstrate just what is necessary to tap into the enthusiasm of
people to make them glad and willing to donate personal data and
samples in order to be part of aworthwhile research undertaking for
the good of humanity. At the very least we see that the science of
medical research is dependent upon the art (and science) of good
communication practiced by those who value and respect the
dignity of every involved individual.
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